Clinical Trials Logo

Bladder Tumor clinical trials

View clinical trials related to Bladder Tumor.

Filter by:

NCT ID: NCT06033040 Recruiting - Clinical trials for Magnetic Resonance Imaging

Medical Imaging in Bladder Tumors by MRI

Start date: August 15, 2023
Phase:
Study type: Observational [Patient Registry]

This study prospectively included 178 patients with bladder neoplastic lesions who planned to undergo surgery (with or without preoperative neoadjuvant chemotherapy). Inclusion criteria: Patients with pathologically confirmed bladder cancer after radical or partial cystectomy or TURBT (< 2 weeks between surgical resection and imaging). Exclusion criteria: 1) Prior history of chemotherapy and/or radiotherapy; 2) No surgical resection; 3) The interval between surgical resection and imaging examination is > 2 weeks; 4) Obvious artifacts; 5)MRI scan contraindications. All subjects underwent pelvic MRI. Data was collected using a Siemens VIDA 3TMR scanner (Siemens Healthcare, Erlangen, Germany). All subjects underwent standardized scanning protocols. The obtained images are post-processed and the experimental results are analyzed statistically.

NCT ID: NCT05872451 Recruiting - Bladder Tumor Clinical Trials

Current Intensity for the Obturator Nerve Block

Current_ONB
Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The purpose of the present study was to find out the difference in current intensity required for nerve stimulation according to the presence or absence of neuromuscular blockade during the obturator nerve block procedure for TURP.

NCT ID: NCT04638569 Recruiting - Bleeding Clinical Trials

Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs

Start date: February 16, 2021
Phase: N/A
Study type: Interventional

Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.

NCT ID: NCT04310813 Completed - Bladder Tumor Clinical Trials

Microscopic-spectroscopic Examination for Urothelial Tissue Characterization

MSUT
Start date: November 1, 2016
Phase:
Study type: Observational

To evaluate the possibility to properly discriminate between healthy bladder tissue and BCa with a multimodal fiber optic spectroscopy (MFOS) technique, in order to possibly introduce a more objective way to detect BCa, thus reducing inter-observer variability and maybe to determine urothelial carcinoma stage and grade with a comparable accuracy, specificity and sensibility of the current gold standard histopathological analysis

NCT ID: NCT04209114 Completed - Bladder Cancer Clinical Trials

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Start date: February 5, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to see if treatment with nivolumab plus bempegaldesleukin or nivolumab alone, before and after surgery to remove the bladder, is more effective than surgery alone in participants with high-risk urothelial cancer, including muscle-invasive bladder cancer who are not able to receive cisplatin chemotherapy.

NCT ID: NCT04081246 Recruiting - Bladder Cancer Clinical Trials

Transurethral Modified En Bloc Resection For Large Bladder Tumours.

Start date: September 7, 2020
Phase: N/A
Study type: Interventional

Modified en bloc resection is a hybrid technique involving piecemeal resection of the exophytic part of the bladder tumour, followed by en bloc resection of the tumour base. In this study, we shall investigate the efficacy of modified en bloc resection for patients with bladder tumours of ≥3cm in size.

NCT ID: NCT03517995 Withdrawn - Bladder Cancer Clinical Trials

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

Start date: April 2020
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to see if Prostaphane is effective and can help reduce the progression of bladder cancer. Researchers also want to find out if Prostaphane is safe and tolerable, and to evaluate how Prostaphane works to reduce the progression of bladder cancer. This study will compare Prostaphane with a placebo to see if taking Prostaphane is better than taking a placebo. A placebo is a pill that looks like Prostaphane but has no drug or other active ingredients in it. The study will be presented to eligible patients by the patient's surgeon at the time when an appointment is made for cystoscopy for suspicion of bladder cancer (BC) or to confirm BC diagnosis.

NCT ID: NCT03331705 Recruiting - Bladder Tumor Clinical Trials

Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures

Start date: November 5, 2016
Phase: N/A
Study type: Observational

This is a prospective, multicenter, single-arm, open-label clinical usability study in subjects who are candidates for office diagnostic cystoscopy. The primary objective of this initial device assessment is to evaluate the performance of a new cystoscope for direct visualization of the urethra and bladder.

NCT ID: NCT03221829 Recruiting - Bladder Tumor Clinical Trials

A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients

Start date: July 6, 2017
Phase: N/A
Study type: Observational

The aim of the study was to evaluate the safety and effectiveness of spinal anesthesia among elderly patients The basic methods for diagnosis and management of bladder cancer include endoscopic procedures (cystoscopy, trans-urethral resection of bladder tumour TURBT). The age of most patients is above 60, which increases the risk of complications during the perioperative period. Usually the leading anaesthesia method in TURBT procedures is regional, mainly spinal, anaesthesia. Although the prevalence of regional upon general anaesthesia is questioned, certain positive aspects of regional anaesthesia are indisputable. Maintaining logical communication with a patient during the procedure enables early diagnosis of complications (TUR syndrome, bladder perforation). Undeniably, regional anaesthesia ensures the best pain management in the early post-operative period. The simplicity of performing an efficacious spinal block and its cost-effectiveness are additional factors, which have contributed to the acknowledgement of the method as the standard of anaesthesia for transurethral procedures.

NCT ID: NCT03029676 Recruiting - Clinical trials for Postoperative Cognitive Dysfunction

The Assessment of POCD After TURBT Under Spinal Anesthesia

Start date: January 1, 2017
Phase: Phase 4
Study type: Interventional

This study evaluates the influence of premedication on cognitive functions in patients undergoing transurethral resection of bladder tumor under spinal anesthesia. The aims of premedication are anxiolysis, analgesia and the reduction of perioperative risk among the patients with comorbidities. The patients will be randomly allocated to receive premedication either with opioid solely or with benzodiazepine combined with opioid. The anesthetic technique is standardized.